MdmX Promotes Bipolar Mitosis To Suppress Transformation and Tumorigenesis in p53-Deficient Cells and Mice

REFERENCES

• Albertson, D. G., C. Collins, F. McCormick, and J. W. Gray. 2003. Chromosome aberrations in solid tumors. Nat. Genet. 34:369–376.
   PubMed Web of Science ®Google Scholar
• Boveri, T. 1902. Ueber mehrpolige Mitosen als Mittel zur Analyse des Zellkerns. Verh. Phys. Med. Ges. Wurzburg 35:67–90.
   Google Scholar
• Brinkley, B. R. 2001. Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends Cell Biol. 11:18–21.
   PubMed Web of Science ®Google Scholar
• Carroll, P. E., M. Okuda, H. F. Horn, P. Biddinger, P. J. Stambrook, L. L. Gleich, Y. Q. Li, P. Tarapore, and K. Fukasawa. 1999. Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression. Oncogene 18:1935–1944.
   PubMed Web of Science ®Google Scholar
• Chiba, S., M. Okuda, J. G. Mussman, and K. Fukasawa. 2000. Genomic convergence and suppression of centrosome hyperamplification in primary p53−/− cells in prolonged culture. Exp. Cell Res. 258:310–321.
   PubMedGoogle Scholar
• Cross, S. M., C. A. Sanchez, C. A. Morgan, M. K. Schimke, S. Ramel, R. L. Idzerda, W. H. Raskind, and B. J. Reid. 1995. A p53-dependent mouse spindle checkpoint. Science 267:1353–1356.
   PubMed Web of Science ®Google Scholar
• Danovi, D., E. Meulmeester, D. Pasini, D. Migliorini, M. Capra, R. Frenk, P. de Graaf, S. Francoz, P. Gasparini, A. Gobbi, K. Helin, P. G. Pelicci, A. G. Jochemsen, and J.-C. Marine. 2004. Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity. Mol. Cell. Biol. 24:5835–5843.
   PubMed Web of Science ®Google Scholar
• D'Assoro, A. B., W. L. Lingle, and J. L. Salisbury. 2002. Centrosome amplification and the development of cancer. Oncogene 21:6146–6153.
   PubMed Web of Science ®Google Scholar
• Finch, R. A., D. B. Donoviel, D. Potter, M. Shi, A. Fan, D. D. Freed, C. Y. Wang, B. P. Zambrowicz, R. Ramirez-Solis, A. T. Sands, and N. Zhang. 2002. mdmx is a negative regulator of p53 activity in vivo. Cancer Res. 62:3221–3225.
   PubMed Web of Science ®Google Scholar
• Finlay, C. A. 1993. The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth. Mol. Cell. Biol. 13:301–306.
   PubMed Web of Science ®Google Scholar
• Francoz, S., P. Froment, S. Bogaerts, S. De Clercq, M. Maetens, G. Doumont, E. Bellefroid, and J. C. Marine. 2006. Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo. Proc. Natl. Acad. Sci. USA 103:3232–3237.
   PubMed Web of Science ®Google Scholar
• Fukasawa, K., T. Choi, R. Kuriyama, S. Rulong, and G. F. Vande Woude. 1996. Abnormal centrosome amplification in the absence of p53. Science 271:1744–1747.
   PubMed Web of Science ®Google Scholar
• Ganguli, G., and B. Wasylyk. 2003. p53-independent functions of MDM2. Mol. Cancer Res. 1:1027–1035.
   PubMed Web of Science ®Google Scholar
• Hansemann, D. 1891. Ueber patologische Mitosen. Arch. Pathol. Anat. Phys. Klin. Med. 119:299–326.
   Google Scholar
• Harvey, M., A. T. Sands, R. S. Weiss, M. E. Hegi, R. W. Wiseman, P. Pantazis, B. C. Giovanella, M. A. Tainsky, A. Bradley, and L. A. Donehower. 1993. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8:2457–2467.
   PubMed Web of Science ®Google Scholar
• Haupt, Y., R. Maya, A. Kazaz, and M. Oren. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387:296–299.
   PubMed Web of Science ®Google Scholar
• Heim, S., N. Mandahl, and F. Mitelman. 1988. Genetic convergence and divergence in tumor progression. Cancer Res. 48:5911–5916.
   PubMed Web of Science ®Google Scholar
• Honda, R., H. Tanaka, and H. Yasuda. 1997. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420:25–27.
   PubMed Web of Science ®Google Scholar
• Inoue, K., R. Wen, J. E. Rehg, M. Adachi, J. L. Cleveland, M. F. Roussel, and C. J. Sherr. 2000. Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis. Genes Dev. 14:1797–1809.
   PubMed Web of Science ®Google Scholar
• Jones, S. N., A. R. Hancock, H. Vogel, L. A. Donehower, and A. Bradley. 1998. Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis. Proc. Natl. Acad. Sci. USA 95:15608–15612.
   PubMed Web of Science ®Google Scholar
• Jones, S. N., A. E. Roe, L. A. Donehower, and A. Bradley. 1995. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378:206–208.
   PubMed Web of Science ®Google Scholar
• Jones, S. N., A. T. Sands, A. R. Hancock, H. Vogel, L. A. Donehower, S. P. Linke, G. M. Wahl, and A. Bradley. 1996. The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of Mdm2. Proc. Natl. Acad. Sci. USA 93:14106–14111.
   PubMed Web of Science ®Google Scholar
• Kadakia, M., T. L. Brown, M. M. McGorry, and S. J. Berberich. 2002. MdmX inhibits Smad transactivation. Oncogene 21:8776–8785.
   PubMed Web of Science ®Google Scholar
• Laurie, N. A., S. L. Donovan, C. S. Shih, J. Zhang, N. Mills, C. Fuller, A. Teunisse, S. Lam, Y. Ramos, A. Mohan, D. Johnson, M. Wilson, C. Rodriguez-Galindo, M. Quarto, S. Francoz, S. M. Mendrysa, R. K. Guy, J. C. Marine, A. G. Jochemsen, and M. A. Dyer. 2006. Inactivation of the p53 pathway in retinoblastoma. Nature 444:61–66.
   PubMed Web of Science ®Google Scholar
• Li, M., C. L. Brooks, F. Wu-Baer, D. Chen, R. Baer, and W. Gu. 2003. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 302:1972–1975.
   PubMed Web of Science ®Google Scholar
• Marine, J. C., M. A. Dyer, and A. G. Jochemsen. 2007. MDMX: from bench to bedside. J. Cell Sci. 120:371–378.
   PubMed Web of Science ®Google Scholar
• Marx, J. 2007. Oncology. Recruiting the cell's own guardian for cancer therapy. Science 315:1211–1213.
   PubMed Web of Science ®Google Scholar
• Migliorini, D., E. L. Denchi, D. Danovi, A. Jochemsen, M. Capillo, A. Gobbi, K. Helin, P. G. Pelicci, and J. C. Marine. 2002. Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development. Mol. Cell. Biol. 22:5527–5538.
   PubMed Web of Science ®Google Scholar
• Miwa, S., C. Uchida, K. Kitagawa, T. Hattori, T. Oda, H. Sugimura, H. Yasuda, H. Nakamura, K. Chida, and M. Kitagawa. 2006. Mdm2-mediated pRB downregulation is involved in carcinogenesis in a p53-independent manner. Biochem. Biophys. Res. Commun. 340:54–61.
   PubMed Web of Science ®Google Scholar
• Montes de Oca Luna, R., D. S. Wagner, and G. Lozano. 1995. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378:203–206.
   PubMed Web of Science ®Google Scholar
• Oliner, J. D., K. W. Kinzler, P. S. Meltzer, D. L. George, and B. Vogelstein. 1992. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358:80–83.
   PubMed Web of Science ®Google Scholar
• Parant, J., A. Chavez-Reyes, N. A. Little, W. Yan, V. Reinke, A. G. Jochemsen, and G. Lozano. 2001. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. Nat. Genet. 29:92–95.
   PubMed Web of Science ®Google Scholar
• Pihan, G. A., A. Purohit, J. Wallace, R. Malhotra, L. Liotta, and S. J. Doxsey. 2001. Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. Cancer Res. 61:2212–2219.
   PubMed Web of Science ®Google Scholar
• Quintyne, N. J., J. E. Reing, D. R. Hoffelder, S. M. Gollin, and W. S. Saunders. 2005. Spindle multipolarity is prevented by centrosomal clustering. Science 307:127–129.
   PubMed Web of Science ®Google Scholar
• Rajagopalan, H., and C. Lengauer. 2004. Aneuploidy and cancer. Nature 432:338–341.
   PubMed Web of Science ®Google Scholar
• Riemenschneider, M. J., R. Buschges, M. Wolter, J. Reifenberger, J. Bostrom, J. A. Kraus, U. Schlegel, and G. Reifenberger. 1999. Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification. Cancer Res. 59:6091–6096.
   PubMed Web of Science ®Google Scholar
• Saunders, W. 2005. Centrosomal amplification and spindle multipolarity in cancer cells. Semin. Cancer Biol. 15:25–32.
   PubMedGoogle Scholar
• Sdek, P., H. Ying, D. L. Chang, W. Qiu, H. Zheng, R. Touitou, M. J. Allday, and Z. X. Xiao. 2005. MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein. Mol. Cell 20:699–708.
   PubMed Web of Science ®Google Scholar
• Shvarts, A., W. T. Steegenga, N. Riteco, T. van Laar, P. Dekker, M. Bazuine, R. C. van Ham, W. van der Houven van Oordt, G. Hateboer, A. J. van der Eb, and A. G. Jochemsen. 1996. MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J. 15:5349–5357.
   PubMed Web of Science ®Google Scholar
• Sluder, G., and J. J. Nordberg. 2004. The good, the bad and the ugly: the practical consequences of centrosome amplification. Curr. Opin. Cell Biol. 16:49–54.
   PubMedGoogle Scholar
• Steinman, H. A., E. Burstein, C. Lengner, J. Gosselin, G. Pihan, C. S. Duckett, and S. N. Jones. 2004. An alternative splice form of Mdm2 induces p53-independent cell growth and tumorigenesis. J. Biol. Chem. 279:4877–4886.
   PubMedGoogle Scholar
• Steinman, H. A., K. M. Hoover, M. L. Keeler, A. T. Sands, and S. N. Jones. 2005. Rescue of Mdm4-deficient mice by Mdm2 reveals functional overlap of Mdm2 and Mdm4 in development. Oncogene 24:7935–7940.
   PubMedGoogle Scholar
• Steinman, H. A., H. K. Sluss, A. T. Sands, G. Pihan, and S. N. Jones. 2004. Absence of p21 partially rescues Mdm4 loss and uncovers an antiproliferative effect of Mdm4 on cell growth. Oncogene 23:303–306.
   PubMedGoogle Scholar
• Stewart, Z. A., S. D. Leach, and J. A. Pietenpol. 1999. p21Waf1/Cip1 inhibition of cyclin E/Cdk2 activity prevents endoreduplication after mitotic spindle disruption. Mol. Cell. Biol. 19:205–215.
   PubMed Web of Science ®Google Scholar
• Storchova, Z., and D. Pellman. 2004. From polyploidy to aneuploidy, genome instability and cancer. Nat. Rev. Mol. Cell Biol. 5:45–54.
   PubMed Web of Science ®Google Scholar
• Toledo, F., and G. M. Wahl. 2006. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat. Rev. Cancer 6:909–923.
   PubMed Web of Science ®Google Scholar
• Vousden, K. H. 2000. p53: death star. Cell 103:691–694.
   PubMed Web of Science ®Google Scholar
• Weaver, B. A., A. D. Silk, C. Montagna, P. Verdier-Pinard, and D. W. Cleveland. 2007. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11:25–36.
   PubMed Web of Science ®Google Scholar